Guest guest Posted April 8, 2003 Report Share Posted April 8, 2003 Journal of Cystic Fibrosis Volume 2, Issue 1 , March 2003, Pages 58-60 Copyright © 2003 European Cystic Fibrosis Society. Published by Elsevier Science B. V. What can we learn from other illnesses? C. Eiser Cancer Research UK Child and Family Research Group, University of Sheffield, Sheffield, UK I would like to begin by putting forward the idea that there is much to be gained from a more generic as opposed to a medical model in working with chronically sick children. I would like to consider the potential advantages of this generic approach, and then go on to consider more specifically what can be learned, firstly, from the specific example of childhood cancer and, secondly, from chronic illness more generally. Whether we work with children with cancer, cystic fibrosis or any other chronic condition, we have to be impressed by the child's capacity to `survive against the odds'. While early work described the problems or deficits shown by sick children, it is now clear that there is huge variability in outcomes. Many children show extraordinary resilience and coping. We are increasingly concerned about quality of life (QOL) as well as quantity of survival. In expanding on the thesis that much can be learned from other diseases, I am going to use QOL as an example. Author 1. Introduction––biomedical vs. non-categorical approaches There is no doubt that there have been impressive advances in medicine that have resulted in much improved survival for children with many previously life-threatening conditions. As survival rates have improved, there has been greater recognition of children's educational, social and family needs. Traditionally, children with chronic diseases been seen in terms of specific diagnoses; they are children with cancer, or children with diabetes. While this is appropriate in some ways, especially with regard to treatment, it is inadequate in others. Chronic illnesses vary along a number of dimensions. Some involve demanding self-care rituals, others very little. Some are life threatening; others more chronic. They all involve a degree of uncertainty. In a non-categorical framework, children with different conditions are grouped together, with greater weight being given to the social and psychological implications of the condition.For most purposes, it is the consequences of illness that affect families, not the label. Chronic conditions have consequences for the child, family, education and health care systems. Often, the label tells us little about the disease manifestations. One child with leukaemia may be severely affected by treatment, be unable to return to school for a year; yet another can sail through treatment in such a way that parents have difficulty recalling that the child has a life-threatening condition at all. At the same time, some apparently different diseases have similar consequences. In both cancer and cystic fibrosis (cf), children can be small and look physically different from their peers. For children, the problems associated with physical appearance can be more important than the labels attached to the conditions.Consequently, in recent years, there have been calls for more `non-categorical' or generic approaches to work with these children. The principal assumptions of the non-categorical approach are that the consequences of specific disease are independent of the diagnosis. It follows that if some dimensions of illness cut across different illnesses, then we can, at least sometimes, benefit from experience gained in other conditions. In the remainder of this talk, I plan to focus first on childhood cancer and then more generally on chronic conditions. 2. The example of childhood cancer Issues of QOL have been central in assessing the impact of treatment of children with cancer since the 1960s. At one level, there is not much point in improving a child's peak flow if it does not make them feel better. The trouble is that children have unique ways of expressing this `feel better' factor. The first problem in devising a measure is in the definition and conceptualisation of the concept. To a large extent, researchers have drawn on definitions of QOL established in work with adults.One of the most successful QOL measures has been proposed by Jim Varni and colleagues [1]. The PedsQL includes five subscales measuring physical, emotional, social, school and general well-being. As an example, the physical QOL subscale requires the child or adult to rate each of eight items on a series of five point Likert scales to indicate the degree of problem experienced over the last four weeks. These items range from the very active (running) through to basic aspects of self-care (Having a bath by him/herself). The measure includes parallel versions for parents and children, which are normalised, and there are also developmentally appropriate versions for children of different ages.In a recent review of the literature, we identified eight measures specifically for children with cancer. It might seem that this choice is a good thing, but in practice it has not been helpful. Measures that are called QOL can include different items and subscale, raising questions about whether or not they are measuring the same construct. In addition, there have been objections to using QOL measures on the grounds that they lack psychometric rigour. Although, there is agreement about the importance of QOL, there is less agreement about its measurement. This raises the question that such a poorly defined concept is inadequate. This conclusion is supported if we look at the status of QOL in work with children with other chronic conditions. 3. Examples from generally chronic illnesses Measurement of QOL is not solely the province of those working with children with cancer. It is generally of interest to all those involved in work with any chronic condition. So we might next ask what could be learned from the wider discussion of QOL issues. I am drawing on a review conducted for the National Health Service in the UK by Morse and myself [2].In this review, we identified 44 separate measures of QOL. These included both generic and disease-specific measures, and versions for parent or child completion separately. Some measures provided parallel versions for parents and children. We identified 19 generic measures and 24 disease specific measures. Among these, we were able to identify just one measure specifically for work with children with cystic fibrosis.It is possible to learn a great deal from this review. Too often, we concluded that researchers set about developing a new measure of QOL, without reviewing the literature generally. Development of new measures is complex and expensive, and it is silly to fail to learn from what has been done before. This includes failing to fully appreciate the views of the child. It is quite inadequate for clinicians and other health professionals to `brain-storm' the content of measures. Neither is it appropriate to adapt a measure developed for adults. Adults and children do not share ideas about the cause, treatment or implications of illness. Children do not have as sophisticated understanding of language, or comparable ability to use rating scales. Thus, both the content and form of measures need to be child-sensitive. 4. Conversely...... So far, I have focused on what can be learned from other illnesses in terms of the implications for work with children with cystic fibrosis. However, in planning this talk, it became clear that there was a related question: what can the rest of the world learn from developments in cystic fibrosis work? Firstly, both children with cancer and those with cystic fibrosis need extensive treatments. Decisions about treatment at home rather than hospital are often justified in terms of cost to the Health Service, but also it is assumed that families prefer home based care. Debates about the merits of home or hospital based care are relevant in the care of children with many chronic conditions, but it is notably in the literature concerning cf that there have been many formal attempts at evaluation.As would be expected, there is evidence of improved clinical outcomes and preferences for home-based care among both families and clinic staff. Wolter et al. [3] used a QOL measure to assess adolescents and young adults on three separate occasions during the course of treatment. At the end of treatment, patients were also asked to rate the degree of disruption to family, personal life, sleeping and eating.Both the duration of treatment and clinical outcomes (respiratory function) were similar between home and hospital-based groups. Unexpectedly, home based patients reported more fatigue, less feelings of mastery, and reduced overall QOL compared with those treated in hospital. However, the home based care group did report improvements in personal, family, sleeping and eating aspects of QOL. The authors suggested that increased fatigue was a consequence of trying to keep up with normal life as well as administer treatments at home.These studies suggest that QOL considerations can improve our understanding of the merits of home-based over hospital-based care. It is not that either method of treatment delivery will have a positive impact on all aspects of QOL, but careful measurement and research can give insights into how patients manage different kinds of care. This is potentially useful in explaining details to new patients and helping them make balanced decisions about, which is right for them. We can all potentially benefit from this kind of work being conducted with children with cystic fibrosis.In our enthusiasm to improve the life of the sick child, we often introduce changes in treatment delivery without checking whether or not these changes will result in improved QOL. However, it is impossible to be sure that changes in treatment delivery have the effects we assume. If treatments are introduced with the aim to improve QOL, it is essential that this is tested rather than assumed. 5. Conclusions––what can be learned? Given my title, I have focused on what can be learned from a generic approach and taken QOL as an example. But I could have equally focused on other issues. Parenting sick children is complex. Parents are responsible for medication and their attitudes to the disease are likely to influence the child's adjustment and adherence. Parenting is an important clinical issue that is relevant to all parents regardless of the child's specific condition. I could also have focused on siblings. Siblings are affected, but again it probably matters less what the specific disease is, compared with the general distress and uncertainty common to all conditions. I could have also focused on school issues. Many children with cancer experience considerable school absence and compromised learning both as a consequence of school absence and adverse effects of medical treatment. Yet, arguments for special educational resources have to be set against the needs of children with other conditions. It may be much more profitable to establish educational back up for children with any chronic disease and this would potentially benefit many more children. There are limited resources available for the kind of social and educational back up services that many of us would like to see. The disease-specific model is essentially counter-productive to the attainment of these resources, to the extent that they engender competition for resource allocation. ation may be better than competition.In conclusion, I would like to thank the organisers of this meeting for inviting me to speak, the National Health Service HTA programme for funding the review of QOL, Cancer Research-UK for funding the work with children with cancer, and the many children and their families who have been willing to take part in our research. Becki YOUR FAVORITE LilGooberGirl YOUNGLUNG EMAIL SUPPORT LIST www.topica.com/lists/younglung Pediatric Interstitial Lung Disease Society http://groups.yahoo.com/group/InterstitialLung_Kids/ Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 8, 2003 Report Share Posted April 8, 2003 Journal of Cystic Fibrosis Volume 2, Issue 1 , March 2003, Pages 58-60 Copyright © 2003 European Cystic Fibrosis Society. Published by Elsevier Science B. V. What can we learn from other illnesses? C. Eiser Cancer Research UK Child and Family Research Group, University of Sheffield, Sheffield, UK I would like to begin by putting forward the idea that there is much to be gained from a more generic as opposed to a medical model in working with chronically sick children. I would like to consider the potential advantages of this generic approach, and then go on to consider more specifically what can be learned, firstly, from the specific example of childhood cancer and, secondly, from chronic illness more generally. Whether we work with children with cancer, cystic fibrosis or any other chronic condition, we have to be impressed by the child's capacity to `survive against the odds'. While early work described the problems or deficits shown by sick children, it is now clear that there is huge variability in outcomes. Many children show extraordinary resilience and coping. We are increasingly concerned about quality of life (QOL) as well as quantity of survival. In expanding on the thesis that much can be learned from other diseases, I am going to use QOL as an example. Author 1. Introduction––biomedical vs. non-categorical approaches There is no doubt that there have been impressive advances in medicine that have resulted in much improved survival for children with many previously life-threatening conditions. As survival rates have improved, there has been greater recognition of children's educational, social and family needs. Traditionally, children with chronic diseases been seen in terms of specific diagnoses; they are children with cancer, or children with diabetes. While this is appropriate in some ways, especially with regard to treatment, it is inadequate in others. Chronic illnesses vary along a number of dimensions. Some involve demanding self-care rituals, others very little. Some are life threatening; others more chronic. They all involve a degree of uncertainty. In a non-categorical framework, children with different conditions are grouped together, with greater weight being given to the social and psychological implications of the condition.For most purposes, it is the consequences of illness that affect families, not the label. Chronic conditions have consequences for the child, family, education and health care systems. Often, the label tells us little about the disease manifestations. One child with leukaemia may be severely affected by treatment, be unable to return to school for a year; yet another can sail through treatment in such a way that parents have difficulty recalling that the child has a life-threatening condition at all. At the same time, some apparently different diseases have similar consequences. In both cancer and cystic fibrosis (cf), children can be small and look physically different from their peers. For children, the problems associated with physical appearance can be more important than the labels attached to the conditions.Consequently, in recent years, there have been calls for more `non-categorical' or generic approaches to work with these children. The principal assumptions of the non-categorical approach are that the consequences of specific disease are independent of the diagnosis. It follows that if some dimensions of illness cut across different illnesses, then we can, at least sometimes, benefit from experience gained in other conditions. In the remainder of this talk, I plan to focus first on childhood cancer and then more generally on chronic conditions. 2. The example of childhood cancer Issues of QOL have been central in assessing the impact of treatment of children with cancer since the 1960s. At one level, there is not much point in improving a child's peak flow if it does not make them feel better. The trouble is that children have unique ways of expressing this `feel better' factor. The first problem in devising a measure is in the definition and conceptualisation of the concept. To a large extent, researchers have drawn on definitions of QOL established in work with adults.One of the most successful QOL measures has been proposed by Jim Varni and colleagues [1]. The PedsQL includes five subscales measuring physical, emotional, social, school and general well-being. As an example, the physical QOL subscale requires the child or adult to rate each of eight items on a series of five point Likert scales to indicate the degree of problem experienced over the last four weeks. These items range from the very active (running) through to basic aspects of self-care (Having a bath by him/herself). The measure includes parallel versions for parents and children, which are normalised, and there are also developmentally appropriate versions for children of different ages.In a recent review of the literature, we identified eight measures specifically for children with cancer. It might seem that this choice is a good thing, but in practice it has not been helpful. Measures that are called QOL can include different items and subscale, raising questions about whether or not they are measuring the same construct. In addition, there have been objections to using QOL measures on the grounds that they lack psychometric rigour. Although, there is agreement about the importance of QOL, there is less agreement about its measurement. This raises the question that such a poorly defined concept is inadequate. This conclusion is supported if we look at the status of QOL in work with children with other chronic conditions. 3. Examples from generally chronic illnesses Measurement of QOL is not solely the province of those working with children with cancer. It is generally of interest to all those involved in work with any chronic condition. So we might next ask what could be learned from the wider discussion of QOL issues. I am drawing on a review conducted for the National Health Service in the UK by Morse and myself [2].In this review, we identified 44 separate measures of QOL. These included both generic and disease-specific measures, and versions for parent or child completion separately. Some measures provided parallel versions for parents and children. We identified 19 generic measures and 24 disease specific measures. Among these, we were able to identify just one measure specifically for work with children with cystic fibrosis.It is possible to learn a great deal from this review. Too often, we concluded that researchers set about developing a new measure of QOL, without reviewing the literature generally. Development of new measures is complex and expensive, and it is silly to fail to learn from what has been done before. This includes failing to fully appreciate the views of the child. It is quite inadequate for clinicians and other health professionals to `brain-storm' the content of measures. Neither is it appropriate to adapt a measure developed for adults. Adults and children do not share ideas about the cause, treatment or implications of illness. Children do not have as sophisticated understanding of language, or comparable ability to use rating scales. Thus, both the content and form of measures need to be child-sensitive. 4. Conversely...... So far, I have focused on what can be learned from other illnesses in terms of the implications for work with children with cystic fibrosis. However, in planning this talk, it became clear that there was a related question: what can the rest of the world learn from developments in cystic fibrosis work? Firstly, both children with cancer and those with cystic fibrosis need extensive treatments. Decisions about treatment at home rather than hospital are often justified in terms of cost to the Health Service, but also it is assumed that families prefer home based care. Debates about the merits of home or hospital based care are relevant in the care of children with many chronic conditions, but it is notably in the literature concerning cf that there have been many formal attempts at evaluation.As would be expected, there is evidence of improved clinical outcomes and preferences for home-based care among both families and clinic staff. Wolter et al. [3] used a QOL measure to assess adolescents and young adults on three separate occasions during the course of treatment. At the end of treatment, patients were also asked to rate the degree of disruption to family, personal life, sleeping and eating.Both the duration of treatment and clinical outcomes (respiratory function) were similar between home and hospital-based groups. Unexpectedly, home based patients reported more fatigue, less feelings of mastery, and reduced overall QOL compared with those treated in hospital. However, the home based care group did report improvements in personal, family, sleeping and eating aspects of QOL. The authors suggested that increased fatigue was a consequence of trying to keep up with normal life as well as administer treatments at home.These studies suggest that QOL considerations can improve our understanding of the merits of home-based over hospital-based care. It is not that either method of treatment delivery will have a positive impact on all aspects of QOL, but careful measurement and research can give insights into how patients manage different kinds of care. This is potentially useful in explaining details to new patients and helping them make balanced decisions about, which is right for them. We can all potentially benefit from this kind of work being conducted with children with cystic fibrosis.In our enthusiasm to improve the life of the sick child, we often introduce changes in treatment delivery without checking whether or not these changes will result in improved QOL. However, it is impossible to be sure that changes in treatment delivery have the effects we assume. If treatments are introduced with the aim to improve QOL, it is essential that this is tested rather than assumed. 5. Conclusions––what can be learned? Given my title, I have focused on what can be learned from a generic approach and taken QOL as an example. But I could have equally focused on other issues. Parenting sick children is complex. Parents are responsible for medication and their attitudes to the disease are likely to influence the child's adjustment and adherence. Parenting is an important clinical issue that is relevant to all parents regardless of the child's specific condition. I could also have focused on siblings. Siblings are affected, but again it probably matters less what the specific disease is, compared with the general distress and uncertainty common to all conditions. I could have also focused on school issues. Many children with cancer experience considerable school absence and compromised learning both as a consequence of school absence and adverse effects of medical treatment. Yet, arguments for special educational resources have to be set against the needs of children with other conditions. It may be much more profitable to establish educational back up for children with any chronic disease and this would potentially benefit many more children. There are limited resources available for the kind of social and educational back up services that many of us would like to see. The disease-specific model is essentially counter-productive to the attainment of these resources, to the extent that they engender competition for resource allocation. ation may be better than competition.In conclusion, I would like to thank the organisers of this meeting for inviting me to speak, the National Health Service HTA programme for funding the review of QOL, Cancer Research-UK for funding the work with children with cancer, and the many children and their families who have been willing to take part in our research. Becki YOUR FAVORITE LilGooberGirl YOUNGLUNG EMAIL SUPPORT LIST www.topica.com/lists/younglung Pediatric Interstitial Lung Disease Society http://groups.yahoo.com/group/InterstitialLung_Kids/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.